Media Articles | ICON plc

ICON experts frequently author or contribute to industry trade press.

Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.

17 October 2022

Providing support throughout the patient journey

Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. Laney Preheim outlines how they can best be implemented.
This article is taken fromInnovations in Pharmaceutical Technology, October 2022, pages 34-36 . Samedan Ltd
10 October 2022

Anthrax vaccine clinical trial

This news article, first published on Contract Pharma.com, outlines how ICON has been selected by BARDA to execute an anthrax vaccine clinical trial.
22 September 2022

Using RWE in rare disease drug development: effective innovations with historical controls

With a growing number of therapies under development for rare diseases, William Maier discusses how real-world evidence can be effectively used as a historical control, overcoming challenges presented in clinical development.
20 September 2022

Robotic Process Automation: Recruiting bots to accelerate clinical trials

Ronan Fox, Senior Vice President of Applied Digital Solutions, contributes his views on the increasing use of RPA in clinical trials.
20 September 2022

Redefining CRO sourcing model terminology to optimise outsourcing strategies

Samir Shah, President, Strategic Solutions at ICON contributes to this Applied Clinical Trials article discussing the compelling need for new terminology for sourcing models in the CRO industry.
Reprinted with permission from Applied Clinical Trials. Applied Clinical Trials is a copyrighted publication of MultiMedia Healthcare, LLC. All rights reserved.
15 September 2022

Embedding the patient point of view in everything you do

Rachel Ballinger, Patient Centred Outcomes Principal, shares the importance of using positive language when speaking with study participants.
14 September 2022

Considerations for vaccine efficacy trials targeting emerging infectious diseases

Following the COVID-19 pandemic, Shelley McLendon outlines what lessons must be learned to prevent future other emerging infectious diseases developing on a similar scale.
This article is taken from European Biopharmaceutical Review October 2022, pages 16-18. Samedan Ltd
01 September 2022

Elite stock: ICON sails through trials with top manager

CFO Brendan Brennan outlines what will drive growth at ICON in his interview with Citywire.
30 August 2022

Supporting reimbursement decisions with data from external control arms

Data is at the heart of every decision made by CROs, and so can have significant legal and financial implications. In this article ICON experts weigh in on maximising the efficacy of data and ensuring the scientific rigour HTAs expect.
This article is taken from European Pharmaceutical Contractor, August 2022, pages 52-55. Samedan Ltd
22 August 2022

Pharmacovigilance outsourcing: Ensuring a positive experience

Karen Johnstone and Sabine Richter discuss current outsourcing practices and tips for selecting a service provider to ensure a successful relationship.